Every round on record, with the sources behind each and the investors on them.
A biotechnology company focusing on longevity and regenerative medicine
lifebiosciences.comLinkedInBangkok, ThailandBiotech
2 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Sources agree. The release identifies Alpha Wave Ventures as the lead and mentions unnamed senior management, founders, funds, investors, and scientists as participants, so no additional named investors can be listed.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series D [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $80M | 2026-04-08 | not stated | No recent discussion |
2 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against its primary page
| ||||
Life Biosciences is a biotechnology company pioneering cellular rejuvenation using epigenetic restoration to reverse diseases of aging.
Life Biosciences is attempting to address age-related disease at a root biological level by using partial epigenetic reprogramming to restore older or injured cells, beginning with optic neuropathies where current care does not repair retinal ganglion-cell damage. Its $80 million Series D is funding the Phase 1 ER-100 trial and broader platform work into the second half of 2027, making the financing a test of whether cellular rejuvenation can move from preclinical science into human therapy.
Checked against 10 sources on Sep 24
Also named as backers in company research: Adam Neumann
| Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $82M | 2022-01-05 | Alpha Wave | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source Sources agree. The release identifies Alpha Wave Ventures as the lead and mentions unnamed senior management, founders, funds, investors, and scientists as participants, so no additional named investors can be listed. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: lifebiosciences.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Series B financing round | $50 million | 2019-01-15 | not stated | |
| Early financing round | $25m | 2017 | not stated | |